Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ResMed Inc. has announced the proposed sale of 74 shares worth approximately $18,419 by Michael J. Rider, an officer of the company, with the transaction facilitated by Fidelity Brokerage Services. These shares, acquired through restricted stock vesting, are set to be sold on December 2, 2024, on the NYSE. The sale reflects a strategic decision by the officer, following previous sales in November 2024.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.